Mark J. Sachleben

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Chanda Kirchner, Attorney-in-Fact for Mark J. Sachleben
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mark J. Sachleben

Form 4 holding Chief Financial Officer

NEW RELIC, INC.

Security class
Common Stock
Shares / value
412,086
Estimated value
$34,615,224
Report date
16 Aug 2022
Price
$84.00
Ownership
By Trust
Form 4 holding Director

ACUITY BRANDS INC

Security class
Stock Units
Shares / value
2,262
Estimated value
$741,936
Report date
22 Jan 2025
Price
$328.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

NEW RELIC, INC.

Security class
Restricted Stock Units
Shares / value
12,315
Estimated value
$714,763
Report date
15 Aug 2022
Price
$58.04
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ACUITY INC. (DE)

Security class
Deferred Restricted Stock Units
Shares / value
546
Estimated value
$175,152
Report date
21 Jan 2026
Price
$328.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

NEW RELIC, INC.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
16 Aug 2022
Price
$84.00
Ownership
Direct

Insider Reports Filed by Mark J. Sachleben

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .